WithdrawnNCT01182857

Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their Parents

Studying Severe combined immunodeficiency due to adenosine deaminase deficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Human Genome Research Institute (NHGRI)
Principal Investigator
Robert A Sokolic, M.D., M.D
National Human Genome Research Institute (NHGRI)
Eligibility
50 years · All sexes
Timeline
2010 – 2014

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01182857 on ClinicalTrials.gov
← Back to all trials